Live Breaking News & Updates on Canntab Therapeutics Inc
Stay updated with breaking news from Canntab therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene. ....
/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene. ....
Canntab Therapeutics Limited: Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp. Company or Canntab ), the leading innovator in cannabinoid and terpene blends in hard pill form for medical and therapeutic applications, is pleased to announce that it has completed its 2 nd (second) delivery of (2) (two) additional SKU s ordered by MediPharm Labs Corp ( MediPharm Labs ) (TSX: LABS) (OTCQX: MEDIF) including 12.5mg CBD caplets (hard tablets in the shape of capsules) and 25mg CBD caplets for approximately $550,000.00. Canntab has now fulfilled 80% of the purchase amount contracted under the wholesale table purchase agreement entered into by the Company and MediPharm Labs in June, 2020. ....
Canntab Therapeutics Limited: Canntab Announces Closing of Convertible Debenture Private Placement Canntab Therapeutics Limited. (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) ( Canntab or the Company ), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the closing of a non-brokered private placement (the Offering ) of secured convertible debentures of the Company ( Convertible Debentures ), pursuant to which the Company issued Convertible Debentures for gross proceeds of $1,575,000 (the Convertible Debentures ). The proceeds will be used to fund working capital for the Company, and for general corporate purposes. The Convertible Debentures are convertible into common shares of the Company (each, a ....